| 2024-11-19 | -1.42 % |
|
| 2024-11-13 | +1.47 % |
|
| 2024-11-08 | +1.98 % |
|
| 2024-11-06 | +2.12 % |
- Cardinal Health (CAH) stock rose 2.12% following positive earnings results that exceeded analyst expectations and an increase in price targets from multiple brokerage firms, indicating strong investor confidence.
- Cardinal Health (CAH) stock rose by 2.12% following the announcement of raised price targets from several brokerages, including Deutsche Bank's increase from $119.00 to $124.00, signaling optimism about the company's performance despite a mixed earnings report.
- Cardinal Health (CAH) stock rose by 2.12% following investment analysts at Mizuho raising its price target from $110.00 to $120.00, indicating potential upside, along with positive earnings results that exceeded expectations.
- Cardinal Health's stock (CAH) rose by 2.12% after positive quarterly earnings, where it beat analysts’ expectations, coupled with several analysts raising their price targets, indicating favorable investor sentiment and confidence in the company's performance.
- Cardinal Health (CAH) stock rose 2.12% after Barclays raised its price target from $117.00 to $133.00, indicating substantial upside potential, along with positive earnings results that exceeded analysts' expectations.
|
| 2024-11-01 | +7.01 % |
|
| 2024-10-31 | +0.58 % |
|
| 2024-10-30 | -1.97 % |
|
| 2024-10-29 | -0.73 % |
|
| 2024-10-28 | -0.02 % |
|
| 2024-10-24 | +0.21 % |
|
| 2024-10-23 | -0.28 % |
|
| 2024-10-18 | +0.43 % |
|
| 2024-10-16 | +0.51 % |
|
| 2024-10-15 | +0.05 % |
|
| 2024-10-14 | -0.52 % |
|
| 2024-10-11 | -1.17 % |
|
| 2024-10-10 | -0.61 % |
|
| 2024-10-09 | +1.7 % |
|
| 2024-10-07 | -0.2 % |
|
| 2024-10-03 | +0.13 % |
|
| 2024-09-27 | +0.51 % |
|
| 2024-09-26 | +0.38 % |
|
| 2024-09-25 | -1.24 % |
|
| 2024-09-24 | -1.48 % |
|
| 2024-09-04 | -0.65 % |
|
| 2024-08-14 | +3.68 % |
- Cardinal Health (CAH) stock rose by 3.68% due to the company's stronger-than-expected profit report for the spring, aligning with a generally positive market reaction to inflation data that suggested potential interest rate cuts by the Federal Reserve.
- Cardinal Health (CAH) stock experienced a 3.68% increase, primarily driven by positive momentum in the broader market and an optimistic outlook for the U.S. economy, leading to increased investor confidence.
- Cardinal Health (CAH) stock rose 3.68% following the company's better-than-expected financial results and an increase in guidance, driven by strong drug sales.
- Cardinal Health Inc. (NYSE: CAH) experienced a 3.68% stock increase following its impressive fourth-quarter and fiscal year 2024 earnings report, which highlighted a 29% rise in earnings per share and a revenue growth of 12%, alongside an upward revision of its fiscal year 2025 guidance, reflecting strong financial performance and confidence in future growth prospects. The stock rose due to the company's robust financial results, strategic investments, and improved outlook which resonate positively with investors, indicating potential for continued value creation.
- Cardinal Health's stock rose by 5.2% after the company raised its 2025 profit forecast, reflecting positive investor sentiment in response to its improved outlook amidst a broader market reaction to slowing inflation in the US.
|
| 2024-08-09 | +1.77 % |
|
| 2024-08-08 | -0.79 % |
|
| 2024-06-14 | -0.41 % |
|
| 2024-06-12 | +0.16 % |
|
| 2024-06-11 | +0.17 % |
|
| 2024-06-07 | -0.29 % |
|
| 2024-06-06 | +0.86 % |
|
| 2024-05-31 | +1.6 % |
|
| 2024-05-30 | +1.63 % |
- Summary: The article compares Sinopharm Group and Cardinal Health based on analyst recommendations, risk, profitability, dividends, valuation, institutional ownership, and earnings, ultimately suggesting that Cardinal Health stock is more favorable due to its higher revenue, earnings, dividend payouts, and institutional ownership. Last night, Cardinal Health stock went up by 1.63%.
Reason for Stock Increase: The Cardinal Health (CAH) stock likely went up due to its higher revenue and earnings compared to its competitor, favorable dividend payouts, and strong institutional ownership.
|
| 2024-05-29 | +1.47 % |
|
| 2024-05-28 | -1.7 % |
- The article reports that Orion Portfolio Solutions LLC increased its holdings in Cardinal Health, Inc. (CAH) by 7.8% during the 4th quarter, but the stock was down 1.7% last night; this decline may be due to factors such as fluctuations in the market, changes in investor sentiment, or other external influences impacting the stock price.
- Summary: Brown Advisory Inc. acquired a new position in Cardinal Health, Inc. (NYSE:CAH) in the fourth quarter, with additional institutional investors and hedge funds making changes to their holdings, while the stock experienced a -1.7% decline; the decrease in stock value might be attributed to various institutions adjusting their positions in CAH.
Reason for Stock Decline: The decrease in Cardinal Health's stock value could be linked to institutional investors and hedge funds making changes to their positions in the company, as discussed in the article.
- The article discusses Hilltop Holdings Inc. increasing its position in Cardinal Health, Inc. (CAH) by 7.4% in the fourth quarter, leading to a rise in institutional ownership and investment in CAH shares; however, CAH stock last night dropped by -1.7% due to various factors such as institutional trading activities, analysts' ratings, and market conditions.
|
